Our mission is to deliver the greatest possible impact to people through mRNA medicines." title="" class="btn" data-container="body" data-html="true" data-id="98348" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Moderna"> 150,822 630,961
Sectors
Location
Novartis Buildings, 200 Technology Square, Cambridge, MA 02139, USA
Cambridge
United States of America
Engaged entities
713Added in Motherbase
23 Feb 2021, 12:10 p.m.Our mission is to deliver the greatest possible impact to people through mRNA medicines.
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.”
Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.
Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients.
We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.
To learn more, visit www.modernatx.com.
This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‐866‐MODERNA (1‐866‐663‐3762).
Biotechnology and mRNA Therapeutics
Pioneering mRNA technology - Moderna France
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Quotient Therapeutics biotech, deeptech | Other 24 Jan 2025 | | ||
Canada-UK Chamber of Commerce e-commerce, International Trade and Development | Other 30 Nov 2024 | | ||
IABS - International Alliance for Biological Standardization healthtech, deeptech | Other 30 Nov 2024 | | ||
Biomedical Science Careers Program (BSCP) edtech | Other 31 Oct 2024 | | ||
PeakBridge Venture Capital and Private Equity Principals | Other 31 Oct 2024 | | ||
Arsenio constructiontech | Other 9 Dec 2024 | | ||
dbt Labs Software Development, it services | Other 9 Dec 2024 | | ||
Venture Valuation AG Financial Services | Other 30 Sep 2024 | | ||
Stratiphy fintech | Other 22 Nov 2024 | | ||
Fetch.ai Software Development, it services | Other 27 Nov 2024 | |